August 21, 2025 · Form 4 insider transaction
D'Silva Andrew J. bought 10,417 shares of OPTIMIZERX CORP at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 47 days after the transaction.
Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.